|
|
||||||||||||||
|
|
|||||||||||||||
production in
trinitrobenzene sulphonic acid induced colitis
C K Ameho
a Department of Nutrition, University of the Ryukyus,
Nishihara, Okinawa 903-01, Japan, b Department of Bacteriology, c Department of Adult Health, d First Department of Pathology, University of the
Ryukyus, e Department of Surgery, St Louis Medical Center, St Louis,
USA, f Daidochuo Hospital, Naha, Okinawa,
Japan, g Department of Nutrition, Kumamoto
Prefectural University, Kumamoto, Japan, h Department of Nutrition, Facultyof Medicine,
University of Tokushima, 3 Kuramoto, Tokushima 770, Japan
Correspondence to: Professor S
Yamamoto. Accepted for publication 25 March 1997 Background Keywords:
glutamine;
trinitrobenzene sulphonic acid;
inflammatory bowel disease;
rats;
interleukin 8;
tumour necrosis factor
It is well established that glutamine
supplemented elemental diets result in less severe intestinal damage in
experimental colitis. However, few studies have examined the mode of
action of glutamine in reducing intestinal damage.
Aims
To examine the effects of glutamine
supplemented elemental diets on the potent inflammatory cytokines
interleukin 8 (IL-8) and tumour necrosis factor
(TNF-
) in
trinitrobenzene sulphonic acid (TNBS) induced colitis which presents
with both acute and chronic features of ulcerative colitis.
Methods
Sprague-Dawley rats were randomised into
three dietary groups and fed 20% casein (controls), or 20% casein
supplemented with either 2% glutamine (2% Gln) or 4% glutamine (4%
Gln). After two weeks they received intracolonic TNBS to induce
colitis.
Results
Both Gln groups of rats gained more weight than
the control group (p<0.05) which had progressive weight loss. Colon weight, macroscopic, and microscopic damage scores for the Gln groups
were lower than in the control group (p<0.05). IL-8 and TNF-
concentrations in inflamed colonic tissues were lower in the Gln groups
than in the control group (p<0.05), and correlated well with disease
severity. Bacterial translocation was lower both in incidence (p<0.05)
and in the number of colony forming units (p<0.05) for the Gln groups,
than in the control group. With respect to all indices studied, the 4%
Gln group performed better than did the 2% Gln group.
Conclusion
Prophylactic glutamine supplementation
modulates the inflammatory activities of IL-8 and TNF-
in TNBS
induced colitis.
(GUT 1997;41:487-493)
This article has been cited by other articles:
![]() |
S. Lecleire, A. Hassan, R. Marion-Letellier, M. Antonietti, G. Savoye, C. Bole-Feysot, E. Lerebours, P. Ducrotte, P. Dechelotte, and M. Coeffier Combined Glutamine and Arginine Decrease Proinflammatory Cytokine Production by Biopsies from Crohn's Patients in Association with Changes in Nuclear Factor-{kappa}B and p38 Mitogen-Activated Protein Kinase Pathways J. Nutr., December 1, 2008; 138(12): 2481 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sokol, B. Pigneur, L. Watterlot, O. Lakhdari, L. G. Bermudez-Humaran, J.-J. Gratadoux, S. Blugeon, C. Bridonneau, J.-P. Furet, G. Corthier, et al. From the Cover: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients PNAS, October 28, 2008; 105(43): 16731 - 16736. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. de Moreno de LeBlanc, J. G. LeBlanc, G. Perdigon, A. Miyoshi, P. Langella, V. Azevedo, and F. Sesma Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice J. Med. Microbiol., January 1, 2008; 57(1): 100 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Coste, L. Dubuquoy, R. Barnouin, J.-S. Annicotte, B. Magnier, M. Notti, N. Corazza, M. C. Antal, D. Metzger, P. Desreumaux, et al. LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease PNAS, August 7, 2007; 104(32): 13098 - 13103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vicario, C. Amat, M. Rivero, M. Moreto, and C. Pelegri Dietary Glutamine Affects Mucosal Functions in Rats with Mild DSS-Induced Colitis J. Nutr., August 1, 2007; 137(8): 1931 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berruyer, L. Pouyet, V. Millet, F. M. Martin, A. LeGoffic, A. Canonici, S. Garcia, C. Bagnis, P. Naquet, and F. Galland Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor {gamma} activity J. Exp. Med., December 25, 2006; 203(13): 2817 - 2827. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hubert-Buron, J. Leblond, A. Jacquot, P. Ducrotte, P. Dechelotte, and M. Coeffier Glutamine Pretreatment Reduces IL-8 Production in Human Intestinal Epithelial Cells by Limiting I{kappa}B{alpha} Ubiquitination J. Nutr., June 1, 2006; 136(6): 1461 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grangette, S. Nutten, E. Palumbo, S. Morath, C. Hermann, J. Dewulf, B. Pot, T. Hartung, P. Hols, and A. Mercenier From The Cover: Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids PNAS, July 19, 2005; 102(29): 10321 - 10326. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rousseaux, B. Lefebvre, L. Dubuquoy, P. Lefebvre, O. Romano, J. Auwerx, D. Metzger, W. Wahli, B. Desvergne, G. C. Naccari, et al. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-{gamma} J. Exp. Med., April 18, 2005; 201(8): 1205 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Alteheld, M. E. Evans, L. H. Gu, V. Ganapathy, F. H. Leibach, D. P. Jones, and T. R. Ziegler Alanylglutamine Dipeptide and Growth Hormone Maintain PepT1-Mediated Transport in Oxidatively Stressed Caco-2 Cells J. Nutr., January 1, 2005; 135(1): 19 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Singer and P. J. Sansonetti IL-8 Is a Key Chemokine Regulating Neutrophil Recruitment in a New Mouse Model of Shigella-Induced Colitis J. Immunol., September 15, 2004; 173(6): 4197 - 4206. [Abstract] [Full Text] [PDF] |
||||
![]() |
T G Moreels, R J Nieuwendijk, J G De Man, B Y De Winter, A G Herman, E A Van Marck, and P A Pelckmans Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats Gut, January 1, 2004; 53(1): 99 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coeffier, S. Claeyssens, B. Hecketsweiler, A. Lavoinne, P. Ducrotte, and P. Dechelotte Enteral glutamine stimulates protein synthesis and decreases ubiquitin mRNA level in human gut mucosa Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G266 - G273. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pavan, P. Desreumaux, and A. Mercenier Use of Mouse Models To Evaluate the Persistence, Safety, and Immune Modulation Capacities of Lactic Acid Bacteria Clin. Vaccine Immunol., July 1, 2003; 10(4): 696 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Salh, K. Assi, V. Templeman, K. Parhar, D. Owen, A. Gomez-Munoz, and K. Jacobson Curcumin attenuates DNB-induced murine colitis Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G235 - G243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coeffier, F. Le Pessot, A. Leplingard, R. Marion, E. Lerebours, P. Ducrotte, and P. Dechelotte Acute Enteral Glutamine Infusion Enhances Heme Oxygenase-1 Expression in Human Duodenal Mucosa J. Nutr., September 1, 2002; 132(9): 2570 - 2573. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-I. Togawa, H. Nagase, K. Tanaka, M. Inamori, T. Umezawa, A. Nakajima, M. Naito, S. Sato, T. Saito, and H. Sekihara Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G187 - G195. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Topilski, A. Harmelin, R. A. Flavell, Y. Levo, and I. Shachar Preferential Th1 Immune Response in Invariant Chain-Deficient Mice J. Immunol., February 15, 2002; 168(4): 1610 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nieto, M. I. Torres, A. Rios, and A. Gil Dietary Polyunsaturated Fatty Acids Improve Histological and Biochemical Alterations in Rats with Experimental Ulcerative Colitis J. Nutr., January 1, 2002; 132(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Desreumaux, L. Dubuquoy, S. Nutten, M. Peuchmaur, W. Englaro, K. Schoonjans, B. Derijard, B. Desvergne, W. Wahli, P. Chambon, et al. Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (RXR)/Peroxisome Proliferator-activated Receptor {{gamma}} (PPAR{{gamma}}) Heterodimer: A Basis for New Therapeutic Strategies J. Exp. Med., April 2, 2001; 193(7): 827 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dombrowicz, S. Nutten, P. Desreumaux, C. Neut, G. Torpier, M. Peeters, J.-F. Colombel, and M. Capron Role of the High Affinity Immunoglobulin E Receptor in Bacterial Translocation and Intestinal Inflammation J. Exp. Med., December 27, 2000; 193(1): 25 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Barbier, C Cherbut, A C Aube, H M Blottiere, and J P Galmiche Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats Gut, December 1, 1998; 43(6): 783 - 790. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |